• 1
    Keslin MH, Jarrell CM, Gregory C. Diagnosis and treatment of allergic rhinitis: primary care in an integrated health system setting. Am J Manag Care 1999;5:248256.
  • 2
    Canonica GW, Holgate ST, Karlsson G, et al. The impact of allergic rhinitis on quality of life and other airway diseases – Summary of a European conference. Allergy 1998;53:731.
  • 3
    International Rhinitis Management Working Group. International Consensus Report on Diagnosis and Management of Rhinitis. Allergy 1994;49:134.
  • 4
    Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol 1997;99:773780.
  • 5
    Apter AJ, Gent JF, Frank ME. Fluctuating olfactory sensitivity and distorted odor perception in allergic rhinitis. Arch Otolaryngol Head Neck Surg 1999;125:10051010.
  • 6
    Van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis – EAACI position paper. Allergy 2000;55:116134.
  • 7
    Dykewicz MS, Fineman S. Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol 1998;81:463468.
  • 8
    Dykewicz MS, Fineman S, Nicklas R, et al. Joint Task Force Algorithm and Annotations for Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol 1998;81:469473.
  • 9
    Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998;81:478518.
  • 10
    Dykewicz MS, Fineman S, Skoner DP. Joint Task Force summary statements on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol 1998;81:474477.
  • 11
    Passali D, Mösges R. International Conference on Allergic Rhinitis in childhood. Allergy 1999;54:434.
  • 12
    Johansson SGO, O'B Hourihane J, Bousquet J, et al. A revised nomenclature for allergy – An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813824.
  • 13
    Campbell DS, Rumley MH. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. JOEM 1997;39:408414.
  • 14
    Jones NS, Carney AS, Davis A. The prevalence of allergic rhinosinusitis: a review. J Laryngol Otol 1998;112:10191030.
  • 15
    Ng TP, Tan WC. Epidemiology of chronic (perennial) rhinitis in Singapore: prevalence estimates, demographic variation and clinical allergy presentation. Ann Acad Med (Singapore) 1994;23:8388.
  • 16
    Goh DYT, Chew FT, Quek SC, Lee BW. Prevalence and severity of asthma, rhinitis, and eczema in Singapore schoolchildren. Arch Dis Child 1996;74:131135.
  • 17
    Zhang L, Chew FT, Soh SY, et al. Prevalence and distribution of indoor allergens in Singapore. Clin Exp Allergy 1997;27:876885.
  • 18
    Chew FT, Goh DYT, Ooi BC, Saharom R, Hui JKS, Lee BW. Association of ambient air-pollution levels with acute asthma exacerbation among children in Singapore. Allergy 1999;54:320329.
  • 19
    Mygind N. Effects of corticosteroid therapy in non-allergic rhinosinusitis. Acta Otolaryngol 1996;116:164166